Drug Free Solution, Inc.
DSOL
$0.0002
$0.000.00%
| 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | 02/28/2013 | |
|---|---|---|---|---|---|
| Net Income | -160.96% | 27.65% | 36.27% | -20.85% | -- |
| Total Depreciation and Amortization | 200.00% | 214.29% | 80.00% | 200.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | 519.02% | -- | -- | -- | -- |
| Cash from Operations | -136.92% | 42.96% | 44.21% | -10.71% | -- |
| Capital Expenditure | -109.85% | -634.69% | 100.00% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -140.15% | -716.33% | 100.00% | 100.00% | -- |
| Total Debt Issued | -- | -200.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 67.80% | -28.78% | -35.37% | 19.25% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -100.00% | -- |
| Cash from Financing | 107.68% | -37.14% | -44.38% | 6.12% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -178.61% | 102.74% | 60.61% | -147.10% | -- |
